Skip to main content
GSK
    • Report a possible side effect
    • Trials in people
    • Sharing our research
  • . Contact us
  • . Search
  • Our Register
  • Clinical Studies
  • Preclinical Publications
  • Report a possible side effect
  • Trials in people
  • Sharing our research
img

GSK long-standing commitment to clinical study transparency

We recognise the importance of publicly disclosing clinical research on our medicines.

img

GSK Study Register

In 2004 we introduced the GSK Study Register a place where anyone can access information about the clinical research we carry out on our medicines. We were the first pharmaceutical company to do this.

img

GSK transparency position

Our clinical study results are made public regardless of whether they are positive or negative for our medicines. When a study begins we post a protocol summary, which includes the study’s objectives and design. Once the study has completed, we provide a summary of the results. We also disclose full protocols, statistical analysis plans, clinical study reports, regulatory overview documents and list studies for data sharing.


Our Clinical Studies

Find an ongoing or completed clinical study.


Our Preclinical Publications

Find citations from preclinical research where there is a GSK author.

Back to Top
GSK
  • ClinicalTrials.gov
  • ClinicalTrialsRegister.eu
  • Our Products
  • Compassionate Use (Expanded Access)
  • Patient Level Data Request System
  • Sitemap
  • Glossary
  • Preparation of Clinical Documents for Public Disclosure
  • Terms of use
  • Cookie policy
  • Privacy
  • Contact GSK

© 2001-2019 GlaxoSmithKline plc. All rights reserved.
GlaxoSmithKline plc. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.